Stephen E. Gitelman
-
- Diabetes Management and Research 52
- Genetics top 0.1%
- Diabetes and associated disorders 52
- Immunology top 1%
- Immune Cell Function and Interaction 5
- Surgery top 0.5%
- Pancreatic function and diabetes 47
- Transplantation top 5%
-
- Electrolyte and hormonal disorders 9
-
- Ion Transport and Channel Regulation 6
- Sexual Differentiation and Disorders 6
- TGF-β signaling in diseases 6
- Co-authors
- Kevan C. HeroldJeffrey A. BluestonePeter A. GottliebRik DerynckEllen FilvaroffWilliam HagopianAdrian ErlebacherCarla J. Greenbaum
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Stephen E. Gitelman
97 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Endocrinology, Diabetes and Metabolism 4.3k
- Genetics 5.4k
- Immunology 2.2k
- Surgery 4.3k
- Transplantation 102
Countries citing papers authored by Stephen E. Gitelman
This map shows the geographic impact of Stephen E. Gitelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Gitelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Gitelman more than expected).
Fields of papers citing papers by Stephen E. Gitelman
This network shows the impact of papers produced by Stephen E. Gitelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Gitelman. The network helps show where Stephen E. Gitelman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen E. Gitelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 54 | |
| 6 | 2021 | 151 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 39 | |
| 9 | 2017 | 21 | |
| 10 | 2016 | 21 | |
| 11 | Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data | 2013 | 12 |
| 12 | 2013 | 3 | |
| 13 | 2011 | 274 | |
| 14 | 2009 | 15 | |
| 15 | 2009 | 140 | |
| 16 | Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Functionbreakdown → | 2009 | 781 |
| 17 | 2007 | 3 | |
| 18 | 1997 | 15 | |
| 19 | 1997 | 110 | |
| 20 | 1992 | 25 |
About Stephen E. Gitelman
Stephen E. Gitelman is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Immunology and Biological Psychiatry, having authored 99 papers that have together received 9.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (52 papers), Diabetes and associated disorders (52 papers), Pancreatic function and diabetes (47 papers), Electrolyte and hormonal disorders (9 papers), Ion Transport and Channel Regulation (6 papers), Sexual Differentiation and Disorders (6 papers), TGF-β signaling in diseases (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.3k citations), Genetics (5.4k citations), Immunology (2.2k citations), Surgery (4.3k citations) and Transplantation (102 citations). Stephen E. Gitelman has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kevan C. Herold, Jeffrey A. Bluestone, Peter A. Gottlieb, Rik Derynck, Ellen Filvaroff, William Hagopian, Adrian Erlebacher, Carla J. Greenbaum, David Donaldson and David M. Harlan. Their work appears in journals such as Diabetes, Diabetes Care, Diabetologia, New England Journal of Medicine and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.